<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Healthcare on FinanClub</title>
    <link>https://finan.club/tags/healthcare/</link>
    <description>Recent content in Healthcare on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 02 Sep 2023 03:08:44 +0000</lastBuildDate><atom:link href="https://finan.club/tags/healthcare/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GH</title>
      <link>https://finan.club/us/gh/</link>
      <pubDate>Sat, 02 Sep 2023 03:08:44 +0000</pubDate>
      
      <guid>https://finan.club/us/gh/</guid>
      <description>score:298
Chances: Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Guardant Health Stock Sees Renewed Technical Strength Guardant Health (GH) Reports Solid Q2 Results Guardant Health Receives Regulatory Approval from Singapore&amp;rsquo;s Health Sciences Authority for Guardant360® CDx blood test Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling Risks: Further weakness as Guardant Health (NASDAQ:GH) drops 3.</description>
    </item>
    
    <item>
      <title>ORCL</title>
      <link>https://finan.club/us/orcl/</link>
      <pubDate>Sat, 02 Sep 2023 03:08:12 +0000</pubDate>
      
      <guid>https://finan.club/us/orcl/</guid>
      <description>score:137
Chances: Oracle Stock Rising On Upgrade: AI Story Still Has Plenty Of Room To Play Out Oracle Stock Rallies as Analyst Sees AI Boost Oracle (ORCL) Enables Royal Flying Doctor Service&amp;rsquo;s Record Oracle (ORCL) Helps MosaicML to Accelerate AI Model Training Oracle Joins White House CancerX Initiative to Aid in the Fight Against Cancer Risks: Stock Market Forecast For The Next Six Months: After Big Gains In Tech Stocks, Eye These Caution Signs Nvidia stock hype is out of control, meaning investors may be overlooking this one key risk Score:137 investment score = chances characters count - risks characters count</description>
    </item>
    
    <item>
      <title>AMZN</title>
      <link>https://finan.club/us/amzn/</link>
      <pubDate>Sat, 02 Sep 2023 02:50:39 +0000</pubDate>
      
      <guid>https://finan.club/us/amzn/</guid>
      <description>score:-28
Chances: Amazon&amp;rsquo;s CAPEX to Exceed $50 Billion in 2023, Partly to Support AI Amazon Adds Cloud Executives, Zoox Chief to Jassy’s Senior Team Like Amazon And Google, Salesforce Is Optimistic About The Remaining Half Of The Year Amazon (AMZN) Integrates Buy With Prime Into Shopify Stores This Is a Huge Win for Amazon&amp;rsquo;s Healthcare Business Risks: Apollo Tries to Salvage Amazon Aggregator Investment With Sale Walgreens CEO out, Amazon&amp;rsquo;s One Medical CEO to depart Amazon stock up $423 billion in market cap amid longest monthly winning streak since 2011 Amazon shareholder sues board, Bezos over Blue Origin launch contracts Amazon Rides High Amid Challenges In Cloud Computing, E-Commerce And FTC Probe Score:-28 investment score = chances characters count - risks characters count</description>
    </item>
    
    <item>
      <title>GSK</title>
      <link>https://finan.club/us/gsk/</link>
      <pubDate>Sat, 12 Aug 2023 07:18:00 +0000</pubDate>
      
      <guid>https://finan.club/us/gsk/</guid>
      <description>score:44
Chances: Approval of Jemperli for new frontline treatment in endometrial cancer. Initiation of separation of consumer healthcare business as part of restructuring plan. Positive Q2 2023 financial results with revenue increase. Growth potential from successful drugs in the pharmaceutical sector. Innovation focus through the use of AI and machine learning.</description>
    </item>
    
    <item>
      <title> NVST</title>
      <link>https://finan.club/us/nvst/</link>
      <pubDate>Tue, 08 Aug 2023 07:00:38 +0000</pubDate>
      
      <guid>https://finan.club/us/nvst/</guid>
      <description>score:1237
Chances: Envista announces successful pricing of $435 million Convertible Senior Notes offering. Consistent growth in Specialty Products &amp;amp; Technologies and Equipment &amp;amp; Consumables segments drive Q2 revenues. Envista delivers positive Q2 2023 earnings and revenue surprises. Envista Smile Project completes mission trip to the Dominican Republic, providing dental care to underserved patients.</description>
    </item>
    
  </channel>
</rss>
